Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies-Reference-Cited by-同舟云学术

Predicting risk for radiographic damage in rheumatoid arthritis: comparative analysis of the multi-biomarker disease activity score and conventional measures of disease activity in multiple studies

Published:2019-03-14 Issue:9 Volume:35 Page:1483-1493
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Curtis Jeffrey R.¹,Brahe Cecilie H.²³,Østergaard Mikkel²³,Lund Hetland Merete²³,Hambardzumyan Karen⁴,Saevarsdottir Saedis⁴⁵,Wang Xingbin⁶,Flake II Darl D.⁷,Sasso Eric H.⁶,Huizinga T. W.⁸

Affiliation:

1. University of Alabama at Birmingham, Birmingham, AL, USA;

2. Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Glostrup, Denmark;

3. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark;

4. Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden;

5. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden;

6. Crescendo Bioscience Inc., South San Francisco, CA, USA;

7. Myriad Genetics Inc., Salt Lake City, UT, USA;

8. Leiden University Medical Center, Leiden, Netherlands

Funder

Crescendo Bioscience Inc.

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1585064

Reference32 articles.

1. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

3. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

4. Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

5. Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stroke risk in rheumatoid arthritis patients: exploring connections and implications for patient care;Clinical and Experimental Medicine;2024-01-31

2. Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?;Clinical Proteomics;2023-06-10

3. Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis;Rheumatology;2022-12-28

4. High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study;Diagnostics;2022-01-13

5. Recommendations and use of multiplex biomarker assays;Immunomodulatory Effects of Nanomaterials;2022